Navigation Links
Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
Date:8/26/2013

OSAKA, Japan and DURHAM, N.C., Aug. 26, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), today announced the initiation of TOMMORROW, a global Phase 3 clinical trial investigating a genetic-based biomarker risk assignment algorithm (risk assignment algorithm) to predict risk of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) within a five year period and to evaluate the efficacy of the investigational low dose pioglitazone (designated AD-4833 for this use) in delaying the onset of MCI due to AD in cognitively normal individuals at high risk as determined by the risk assignment algorithm.

The risk assignment algorithm is comprised of apolipoprotein E (APOE) and TOMM40 genotypes and age. Age and APOE genotype have previously been shown to indicate elevated risk of AD. The addition of TOMM40 is hypothesized to further refine the risk determination.

"To date, there have been a number of avenues investigated with the goal of altering the course of Alzheimer's disease but results have been unsuccessful," said Allen Roses, M.D., Chief Executive Officer, Zinfandel. "This is why the TOMMORROW trial is important. The potential to identify an individual's risk for developing MCI due to AD warrants further investigation."

AD is a devastating disease and diagnoses are increasing as the world's population ages. Currently 35.6 million people worldwide are living with some form of dementia. Studies show that individuals with MCI are at an increased risk of developing AD or another dementia with conversion rates of approximately 15 percent per year.

"AD-4833 is a member of a class of drugs known as PPAR (peroxisome proliferator-activated receptor)-gamma agonists which available data show may have a beneficial role in delaying symptoms of MCI due to AD," noted '/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Launches New Subsidiary in Peru
2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
3. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
4. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
5. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
6. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
7. Takeda to Acquire Inviragen, Inc.
8. Takeda Responds to Verdict in Diabetes Drug Case
9. Takeda Launches New Subsidiary in Ecuador
10. Takeda lanza nueva subsidiaria en Ecuador
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... LITTLETON, Mass. , May 5, 2015  Image ... announces a new agreement with MedAssets, one of the ... hospitals in the United States.  Under terms of the ... products, accessories, and services will be made available to ... In announcing the partnership, Image Stream Medical CEO ...
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory,Molecular Diagnostics and Genomic Testing Services ... Asia Pacific Version" report to their offering. ... growing. Clinical laboratory testing is positioned to directly ... A range of dynamic trends are pushing market ...
(Date:5/5/2015)... BOULDER, Colo. , May 5, 2015  As cannabis prohibition ends one state at a time, more cannabis entrepreneurs are ... past the idea phase, and the primary reason is lack of funding. ... ... ... ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4
... was associated with fewer missed work days and less impairment ... - Final Albuferon Phase 2b quality-of-life data presented at the Annual,Meeting of the ... ... -, ROCKVILLE, Md., Nov. 5 Human Genome ...
... Nov. 2 /PRNewswire/,-- Fabre-Kramer Pharmaceuticals Inc. (FKP) and ... U.S. Food and Drug Administration (FDA) has issued,a ... for gepirone extended-,release (ER) tablets, submitted for the ... FDA had previously reviewed Phase I through III ...
Cached Medicine Technology:Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 2Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 3Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 4Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 5Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 6Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C 7Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder 2
(Date:5/5/2015)... 05, 2015 Information Innovators ... serving the federal government, today announced its acquisition ... CCSi provides solutions exclusively to federal government customers ... in cyber security, health services, and program management ... industry-relevant credentials as a Third Party Assessment Organization ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 On May, 5, ... with Charleston musician Irene Rose about alternatives for youngsters to ... “How did you get the idea for starting a summer ... “I run an entertainment company called Once Upon a Party ... moral lessons through songs and even scripture. We play games, ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 RF Technologies®, ... created the Sensatec® ST750 Fall Management Solution with Voice ... the monitored patient or resident to wait for assistance ... also have the choice of 16 different melodies or ... nurse call system such as Code Alert®. , ...
(Date:5/5/2015)... Major League Ultimate (MLU) was founded by ... Frisbee™ is home to many amazing athletes, dramatic moments, ... world. Nike Ultimate Camps’ goal of spreading the sport ... athletes to learn about the sport and develop their ... , The Nike Ultimate Camp in Philadelphia by MLU ...
(Date:5/5/2015)... 2015 NovaSom, Inc., announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... This segment will focus on NovaSom, a leader in ... about their AccuSom® home sleep test, which is the ... patient support and next-day test results and interpretation. ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3Health News:US Sports Camps, Nike Ultimate Camps, and Major League Ultimate Host Youth Ultimate Summer Camps in Philidelphia 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2
... gatekeeper leads to the development of arthritis in mice, scientists ... Experimental Medicine . The newly discovered gatekeeper is a protein ... damaging cells that mistakenly attack the body,s own tissues and ... Better understanding how arthritis develops will offer scientists an opportunity ...
... Group, or SWOG, one of the nation,s largest cancer clinical ... in their careers for its 2010 Young Investigator Training Course ... 15 in Seattle, WA for intensive training in how ... this nationally acclaimed program has provided intensive mentorship and career ...
... Researchers in Cedars-Sinai,s Department of Psychiatry and Behavioral ... changes in their body,s immune and endocrine response. ... the health benefits of massage, the Cedars-Sinai study is ... a larger group of healthy adults. ...
... owes as much to art as it does science ... with large scale industry. Confectionery and Chocolate ... of Professor Ferenc Mohos, inside experience to reveal how ... to this unique industry. "Confectionery is usually associated ...
... Reinberg HealthDay Reporter , TUESDAY, Sept. 7 (HealthDay ... 20 percent of Americans still light up, U.S. health officials ... 2000 and 2005, but the decline has leveled out, according ... Control and Prevention (CDC). , "The 40-year decline in tobacco ...
... of the 354 million annual visits for acute care in ... Americans increasingly make busy emergency departments, specialists or outpatient care ... health problems or a flare up of a chronic condition ... in the September edition of Health Affairs , do ...
Cached Medicine News:Health News:Scientists identify molecular gatekeeper of arthritis 2Health News:Scientists identify molecular gatekeeper of arthritis 3Health News:SWOG names 5 cancer researchers outstanding Young Investigators 2Health News:SWOG names 5 cancer researchers outstanding Young Investigators 3Health News:Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show 2Health News:Confectionery and chocolate engineering: Principles and applications 2Health News:Decline in Adult Smoking Stalls, Alarming Experts 2Health News:Decline in Adult Smoking Stalls, Alarming Experts 3Health News:Study finds more Americans bypassing their personal physician when immediate treatment required 2Health News:Study finds more Americans bypassing their personal physician when immediate treatment required 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: